Uncontrolled hypertension among patients with comorbidities in sub-Saharan Africa: protocol for a systematic review

Shukri F Mohamed1,2,3, Olalekan A Uthman4, Rishi Caleyachetty5

  • 1Academic Unit of Primary Care (AUPC) and the NIHR Global Health Research Unit on Improving Health in Slums, University of Warwick, Coventry, UK. Shukri.Mohamed@warwick.ac.uk.

Systematic Reviews
|January 18, 2020
PubMed

Insights

Uncontrolled hypertension is a major cardiovascular risk, especially in sub-Saharan Africa. This review quantifies its prevalence in patients with comorbidities to inform public health strategies.

Area of Science:

  • Cardiology
  • Public Health
  • Epidemiology

Background:

  • Uncontrolled hypertension is a leading cause of cardiovascular disease globally.
  • Sub-Saharan Africa faces the highest prevalence of uncontrolled hypertension, with low treatment rates.
  • Hypertension frequently co-exists with comorbidities, worsening patient outcomes.

Purpose of the Study:

  • To estimate the prevalence of uncontrolled hypertension among patients with comorbidities in sub-Saharan Africa.
  • To provide data for guiding public health policies and interventions in the region.
  • To quantify the burden of uncontrolled hypertension in this vulnerable population.

Main Methods:

  • Systematic review and meta-analysis of published and unpublished studies (2000-2019).
  • Searches of MEDLINE, Embase, and Web of Science; expert consultation; Open SIGLE review.
  • Data extraction and bias assessment by two reviewers, with arbitration by a third; random effects model for meta-analysis.

Main Results:

  • The review will quantify the prevalence of uncontrolled hypertension in patients with comorbidities in sub-Saharan Africa.
  • Results will be stratified by country, comorbidity, and geographic region for detailed insights.
  • Publication bias will be assessed using Egger's test and funnel plots.

Conclusions:

  • This systematic review and meta-analysis will provide crucial data on uncontrolled hypertension prevalence in sub-Saharan Africa.
  • Findings are expected to inform targeted interventions and health policies to mitigate cardiovascular disease risks.
  • The study aims to improve health outcomes for patients with hypertension and comorbidities in the region.
Abstract

Related Concept Videos

Hypertension III: Clinical Manifestations and Diagnostic Studies01:30

Hypertension III: Clinical Manifestations and Diagnostic Studies

Hypertension is asymptomatic and also referred to as the "silent killer" until it progresses to a severe stage or causes target organ disease. Patients may experience symptoms stemming from the strain on blood vessels and tissues in various organs or the heart's increased workload.Physical exams might show no abnormalities other than high blood pressure. Signs of vascular damage, when present, correspond to the organs supplied by the affected vessels, leading to target organ damage. For...
385
Hypertension IV: Drug Therapy and Lifestyle Modifications01:28

Hypertension IV: Drug Therapy and Lifestyle Modifications

Multiple classes of antihypertensive medications are employed in treating hypertension. The most commonly recommended first-line treatments include:Thiazide Diuretics, such as chlorthalidone, increase sodium and water excretion from the body, reducing blood volume and blood pressure.Angiotensin-converting enzyme inhibitors, like lisinopril, block the conversion of angiotensin I to II, a potent vasoconstrictor lowering blood pressure.Angiotensin II Receptor Blockers (ARBs) prevent angiotensin II...
507
Hypertension II: Pathophysiology01:29

Hypertension II: Pathophysiology

Hypertension is a chronic condition in which the blood's force against artery walls is excessively high, posing risks such as heart disease. The condition's underlying mechanisms involve complex interactions among the cardiovascular, kidney, and autonomic nervous systems.Renin-Angiotensin-Aldosterone System (RAAS): This system significantly influences blood pressure regulation. When blood pressure decreases, the kidneys secrete renin. This enzyme transforms angiotensinogen, a plasma protein,...
644
Hypertension I: Introduction01:28

Hypertension I: Introduction

Hypertension is a widespread, long-term medical condition where blood pressure in the arteries remains elevated. It is characterized by systolic blood pressure readings of 130 mm Hg or above or diastolic blood pressure (DBP) readings of 80 mm Hg or higher. Unmanaged hypertension poses significant health risks, making the distinction between primary (or essential) hypertension and secondary hypertension crucial, as their management and implications vary.Primary HypertensionPrimary hypertension,...
601
Hypertension and Regulation of Blood Pressure01:18

Hypertension and Regulation of Blood Pressure

Hypertension, the most common cardiovascular disease, is diagnosed through repeated measurements of elevated blood pressure. Its risks, including damage to the kidney, heart, and brain, are directly proportional to blood pressure levels. Starting from 115/75 mm Hg, the risk of cardiovascular disease doubles with each increment of 20/10 mm Hg. The diagnosis relies on blood pressure measurements, not on patient symptoms, as hypertension is often asymptomatic until end-organ damage is imminent or...
3.6K
Errors occurring during blood pressure monitoring01:25

Errors occurring during blood pressure monitoring

Blood pressure monitoring is a crucial clinical procedure in diagnosing and managing various cardiovascular conditions. Despite its significance, the accuracy of blood pressure measurements can be compromised by multiple factors, potentially leading to either falsely high or low readings. These inaccuracies are critical as they can significantly impact patient care. So, it is vital to understand these challenges deeply and adopt strategic approaches to minimize errors.
Several factors...
1.3K